Antacids Market Size
|Study Period||2018 - 2028|
|Base Year For Estimation||2022|
|Fastest Growing Market||Asia Pacific|
|Largest Market||North America|
*Disclaimer: Major Players sorted in no particular order
Need a report that reflects how COVID-19 has impacted this market and its growth?
Antacids Market Analysis
The Global Antacids Market size is expected to grow from USD 6,810.11 million in 2023 to USD 8,194.33 million by 2028, registering a CAGR of 3.7% during the forecast period (2023-2028).
The COVID-19 pandemic significantly impacted the market due to declining production and a labor shortage. The prices were higher than normal. However, because of the rising demand for new antacids and other medications, the market witnessed a favorable impact. This significantly increased the revenue of the market under study. Additionally, it was shown that various gastrointestinal medications successfully enhanced the clinical results of COVID-19 patients who were hospitalized. For instance, as per an article published in the View Open Access Journal in May 2022, acidosis-related pH promoted SARS-CoV-2 infection and suggested the existence of a positive feedback loop in which SARS-CoV-2 infection-induced acidosis enhances SARS-CoV-2 infection. Therefore, antacid therapy for acidosis COVID-19 patients was necessary during the pandemic. As per the above source, calcium carbonate nanoparticles (CaCO3-NPs) were an effective antacid nano antidote than sodium bicarbonate. Hence, the use of these medications increased during the pandemic and fueled the overall market growth. The studied market is anticipated to maintain its stronghold and grow significantly during the forecast period.
Factors such as the growing geriatric population suffering from gastroesophageal reflux disease (GERD), poor lifestyle choices leading to higher incidences of acidity, and side effects of drugs like non-steroidal, anti-inflammatory drugs are predicted to contribute to the market's growth over the analysis period.
As per a report released in May 2021 by HHS's Administration on Aging (AoA), the number of geriatric populations is expected to rise to 94.7 million by 2060. As per various sources, with the aging of the population, GERD is more common, with a prevalence of 20% or higher in the outpatient setting. Hence, the rising geriatric population is expected to rise, and the demand for antacids to treat GERD. Therefore, the market studied is anticipated to expand and grow during the forecast period.
Furthermore, according to a research report published in the Cureus journal in November 2021, the prevalence of GERD was 20.6% in the eastern region of Saudi Arabia. Numerous sociodemographic and lifestyle factors were linked to the illness. Therefore, rising prevalence would boost antacid demand and support market expansion over the projected period.
However, the growing number of alternatives available in the market to antacids and the ignorance of people towards the symptoms of acidity are expected to have an adverse impact on the market growth.
Antacids Market Trends
Tablet Segment is Expected to Witness Growth Over the Forecast Period
The presence of various chewable tablets in the market with different flavors that help improve patient adherence to the medication is expected to contribute to the segment's growth. Tablets also provide the correct dosage amount to the patients, and they are easy to store. These factors can be attributed to the segment growth over the forecast period. Tablets are the most widely used solid dosage forms as compared to other forms.
The growing geriatric population is expected to drive market growth as the elderly population is more prone to gastrointestinal disorders. According to the data from the World Population Prospects 2022 revision, the world may witness a rise in the aging population, which is expected to reach 70 million by 2059. Thus, with the geriatric population increasing globally, the demand for antacids is also expected to increase and fuel the segment's growth.
Furthermore, the major market players focus on research and development activities to bring new and reliable products. For instance, Generic Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules for the treatment of stomach ulcers, irritable bowel syndrome, and colon inflammation were introduced to the United States market by Dr. Reddy's Laboratories in August 2021. Besides, product approval is also contributing to market growth. For instance, glycopyrrolate orally disintegrating tablets (Dartisla ODT; Edenbridge Pharmaceuticals) were approved by the United States Food and Drug Administration (FDA) in December 2021 to treat peptic ulcers and lessen their symptoms. These approvals are predicted to accelerate market growth. As a result of the factors above, the segment is anticipated to increase significantly over the forecast period.
To understand key trends, Download Sample Report
North America is Expected to Hold a Significant Share of the Market Over the Forecast Period
The North American antacids market is expected to grow significantly due to increasing gastroesophageal reflux disease (GERD) and lifestyle changes leading to gastrointestinal problems among the American population.
The trend toward self-medication in North American countries such as the United States is increasing the demand for over-the-counter digestive products, such as antacids. In addition, one of the main elements influencing market expansion is product approval. For instance, the United States Food and Drug Administration (FDA) gave Zydus Lifesciences final approval in June 2022 to market Famotidine tablets in strengths of 20 and 40 mg. A histamine H2 receptor blocker is famotidine. It functions by lessening the stomach's acid production. As a result of the factors above, the market under study is anticipated to increase significantly over the forecast period.
Furthermore, according to an article published in the Annals of the Esophagus in March 2022, approximately 40% of the population of the United States annually experience GERD symptoms, with 10-20% of people being affected weekly in the country. Such a high burden of GERD in the country is anticipated to contribute to the overall market growth in the region.
To understand geography trends, Download Sample Report
Antacids Industry Overview
The antacids market is moderately competitive and faces intense competition over the forecast period due to multinational players and small to medium-sized companies entering the market. The major players in the studied market are Johnson and Johnson, Haleon, Sanofi S.A., Bayer AG, and Sun Pharmaceuticals Ltd. The key players have adopted strategies such as strategic acquisitions, collaborations, and partnerships, which will help them expand their geographical presence and strengthen their business position.
Antacids Market Leaders
Sun Pharmaceuticals Ltd
Johnson & Johnson
*Disclaimer: Major Players sorted in no particular order
Antacids Market News
- March 2023: Wonderbelly, a digestive medicine company, launched three antacid flavors, one of which, Fruity Cereal, at select Target stores, being exclusive to the retailer.
- June 2022: Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in 20 and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.
Antacids Market Report - Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Geriatric Population Suffering from Gastroesophageal Reflux Disease (GERD)
4.2.2 Poor Lifestyle Choices Leading to Higher Incidences of Acidity
4.2.3 Side Effects of Drugs like Non-Steroidal Anti-Inflammatory Drugs
4.3 Market Restraints
4.3.1 Ignorance of People towards Symptoms of Acidity
4.3.2 Growing Number of Alternatives in the Market for Antacids
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Formulation Type
5.1.3 Other Formulation Types
5.2 By Distribution Channel
5.2.1 Hospital Pharmacies
5.2.3 Other Distribution Channels
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.3 Johnson & Johnson
6.1.4 Sun Pharmaceuticals Ltd.
6.1.5 Sanofi S.A
6.1.6 WellSpring Pharmaceutical Corporation
6.1.7 Advance Pharmaceutical Inc.
6.1.8 CVS Pharmacy
6.1.9 Safetec of America, Inc.
6.1.10 Reckitt Benckiser Group plc.
6.1.11 Takeda Pharmaceutical Company Limited
6.1.12 Procter & Gamble
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Antacids Market Research FAQs
What is the study period of this market?
The Antacids Market is studied from 2018 - 2028.
What is the growth rate of Antacids Market?
The Antacids Market is growing at a CAGR of 3.7% over the next 5 years.
Which region has highest growth rate in Antacids Market?
Asia Pacific is growing at the highest CAGR over 2018 - 2028.
Which region has largest share in Antacids Market?
North America holds highest share in 2022.
Who are the key players in Antacids Market?
Sun Pharmaceuticals Ltd, Sanofi S.A, Bayer AG, Johnson & Johnson, Haleon are the major companies operating in Antacids Market.
Global Antacids Industry Report
Statistics for the 2023 Antacids market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Antacids analysis includes a market forecast outlook to for 2023 to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.